GERARDO MAZZELLA

 GERARDO MAZZELLA

Heart Rhythm

Log inRegisterSubscribeClaim


CLINICAL ATRIAL FIBRILLATION| VOLUME 15, ISSUE 7, P971-979, JULY 01, 2018

Does the CHA2DS2-VASc score reliably predict atrial arrhythmias? Analysis of a nationwide database of remote monitoring data transmitted daily from cardiac implantable electronic devices

Purchase

Subscribe

Save

Share

Reprints

Request

Top

Does the CHA2DS2-VASc score reliably predict atrial arrhythmias? Analysis of a nationwide database of remote monitoring data transmitted daily from cardiac implantable electronic devices

Giovanni Rovaris, MD 

Francesco Solimene, MD

Antonio D'Onofrio, MD

Daniele Giacopelli, MSc

Alessio Gargaro, MSc

Ennio C. Pisanò, MD

Show all authors

Published:February 22, 2018DOI:https://doi.org/10.1016/j.hrthm.2018.02.023

PlumX Metrics

Keywords

References

Article Info

Related Articles

Background

CHA 2DS 2-VASc is a validated score for predicting stroke in patients with atrial fibrillation (AF).

Objective

The purpose of this study was to assess whether the CHA 2DS 2-VASc score can predict new-onset AF in a cohort of patients with a cardiac implantable electronic device (CIED) followed with remote monitoring.

Methods

Using the database of the Home Monitoring Expert Alliance project, we selected 2410 patients with no documented AF who had received a CIED with diagnostics on atrial high rate episodes (AHREs). The primary endpoint was time to first day with cumulative AHRE burden ≥15 minutes, 5 hours, 24 hours, and ≥7 consecutive days.

Results

During a median duration of 24.1(11.5–42.9) months, the incidence of AHRE increased with increasing CHA 2DS 2-VASc. At 6 years, occurrence of ≥15-minute AHRE was 80.2% (CHA 2DS 2-VASc ≤1) vs 93.7% (CHA 2DS 2-VASc ≥5), whereas ≥5-hour AHRE incidence was 68.4% (CHA 2DS 2-VASc ≤1) vs 92.5% (CHA 2DS 2-VASc ≥5). Occurrence of ≥24-hour and ≥7-day AHREs also increased with increasing CHA 2DS 2-VASc: 9.1% and 3.9% (CHA 2DS 2-VASc ≤1) vs 40.4% and 28.7% (CHA 2DS 2-VASc ≥5), respectively. Adjusted hazard ratio for unitary CHA 2DS 2-VASc increase ranged from 1.09 (confidence interval 1.04–1.14; P <.001) with AHRE burden ≥15 minutes to 1.26 (confidence interval 1.11–1.42; P <.001) with AHRE burden ≥7 days. At receiver operating curve analysis, CHA 2DS 2-VASc ≥2 was estimated to predict persistent forms of AHREs with 95.8% sensitivity but 11.7% specificity at 3 years. CHA 2DS 2-VASc ≥5 had 77.0% specificity but 34.6% sensitivity.

Conclusion

In a CIED population with no previous diagnosis of clinical AF, AHRE incidence increased with increasing CHA 2DS 2-VASc score. The association was stronger with longer AHREs, but the accuracy of CHA 2DS 2-VASc as AHRE predictor was moderate.


GERARDO MAZZELLA

Keywords

Atrial fibrillation

Cardiac implantable electronic device

CHA2DS2-VASc score

Clinical predictor

Remote monitoring

To read this article in full you will need to make a payment

Purchase one-time access

Subscribe to Heart Rhythm

Already a print subscriber? Claim online access

Already an online subscriber? Sign in

Register: Create an account

Institutional Access: Sign in to ScienceDirect

References

Wolf P.A.

Abbott R.D.

Kannel W.B.

Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study.

Arch Intern Med. 1987; 147: 1561-1564

View in Article

Scopus (1188)

PubMed

Crossref

Google Scholar

Mattle H.P.

Long-term outcome after stroke due to atrial fibrillation.

Cerebrovasc Dis. 2003; 16: 3-8

View in Article

Scopus (30)

PubMed

Crossref

Google Scholar

Lin H.J.

Wolf P.A.

Kelly-Hayes M.

Beiser A.S.

Kase C.S.

Benjamin E.J.

D'Agostino R.B.

Stroke severity in atrial fibrillation. The Framingham Study.

Stroke. 1996; 27: 1760-1764

View in Article

Scopus (923)

PubMed

Crossref

Google Scholar

Lip G.Y.

Nieuwlaat R.

Pisters R.

Lane D.A.

Crijns H.J.

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation.

Chest. 2010; 137: 263-272

View in Article

Scopus (3488)

PubMed

Abstract

Full Text

Full Text PDF

Google Scholar

Kirchhof P.

Benussi S.

Kotecha D.

et al.

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

Eur Heart J. 2016; 37: 2893-2962

View in Article

Scopus (3186)

PubMed

Crossref

Google Scholar

Nasir J.M.

Pomeroy W.

Marler A.

Hann M.

Baykaner T.

Jones R.

Stoll R.

Hursey K.

Meadows A.

Walker J.

Kindsvater S.

Predicting Determinants of Atrial Fibrillation or Flutter for Therapy Elucidation in Patients at Risk for Thromboembolic Events (PREDATE AF) Study.

Heart Rhythm. 2017; 14: 955-961

View in Article

Scopus (46)

PubMed

Abstract

Full Text

Full Text PDF

Google Scholar

Saliba W.

Gronich N.

Barnett-Griness O.

Rennert G.

Usefulness of CHADS2 and CHA2DS2-VASc scores in the prediction of new-onset atrial fibrillation: a population-based study.

Am J Med. 2016; 129: 843-849

View in Article

Scopus (46)

PubMed

Abstract

Full Text

Full Text PDF

Google Scholar

Slotwiner D.

Varma N.

Akhar J.G.

et al.

HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular implantable electronic devices.

Heart Rhythm. 2015; 12: e69-e100

View in Article

Scopus (167)

PubMed

Abstract

Full Text

Full Text PDF

Google Scholar

He Y.

Missing data analysis using multiple imputation: getting to the heart of the matter.

Circ Cardiovasc Qual Outcomes. 2010; 3: 98-105

View in Article

Scopus (127)

PubMed

Crossref

Google Scholar

Heagerty P.J.

Lumley T.

Pepe M.S.

Time-dependent ROC curves for censored survival data and a diagnostic marker.

Biometrics. 2000; 56: 337-344

View in Article

Scopus (1144)

PubMed

Crossref

Google Scholar

Curtis A.B.

Hattoum A.

The who, how, and why of screening patients for atrial fibrillation: More questions than answers.

Heart Rhythm. 2017; 14: 962-963

View in Article

Scopus (1)

PubMed

Abstract

Full Text

Full Text PDF

Google Scholar

Guerra F.

Scappini L.

Maolo A.

Campo G.

Pavasini R.

Shkoza M.

Capucci A.

CHA2DS2-VASc risk factors as predictors of stroke after acute coronary syndrome: a systematic review and meta-analysis.

Eur Heart J Acute Cardiovasc. 2016; ([Epub ahead of print])

View in Article

Scopus (5)

PubMed

Crossref

Google Scholar

Mitchell L.B.

Southern D.A.

Galbraith D.

Ghali W.A.

Knudtson M.

Wilton S.B.

APPROACH Investigators. Prediction of stroke or TIA in patients without atrial fibrillation using CHADS2 and CHA2DS2-VASc scores.

Heart. 2014; 100: 1524-1530

View in Article

Scopus (99)

PubMed

Crossref

Google Scholar

Ricci R.P.

Glotzer T.V.

Home screening for detecting subclinical atrial fibrillation.

J Atr Fibrillation. 2015; 8: 1326

View in Article

PubMed

Google Scholar

Glotzer T.V.

Daoud E.G.

Wyse D.G.

Singer D.E.

Ezekowitz M.D.

Hilker C.

Miller C.

Qi D.

Ziegler P.D.

The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study.

Circ Arrhythm Electrophysiol. 2009; 2: 474-480

View in Article

Scopus (516)

PubMed

Crossref

Google Scholar

Healey J.S.

Connolly S.J.

Gold M.R.

et al.

Subclinical atrial fibrillation and the risk of stroke.

N Engl J Med. 2012; 366: 120-129

View in Article

Scopus (1120)

PubMed

Crossref

Google Scholar

Mabo P.

Victor F.

Bazin P.

Ahres S.

Babuty D.

Da Costa A.

Binet D.

Daubert J.C.

COMPAS Trial Investigators

A randomized trial of long-term remote monitoring of pacemaker recipients (the COMPAS trial).

Eur Heart J. 2012; 33: 1105-1111

View in Article

Scopus (179)

PubMed

Crossref

Google Scholar

Ricci R.P.

Vaccari D.

Morichelli L.

et al.

Stroke incidence in patients with cardiac implantable electronic devices remotely controlled with automatic alerts of atrial fibrillation. A sub-analysis of the HomeGuide study.

Int J Cardiol. 2016; 219: 251-256

View in Article

Scopus (7)

PubMed

Abstract

Full Text

Full Text PDF

Google Scholar

Martin D.T.

Bersohn M.M.

Waldo A.L.

Wathen M.S.

Choucair W.K.

Lip G.Y.

Ip J.

Holcomb R.

Akar J.G.

Halperin J.L.

IMPACT Investigators. Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices.

Eur Heart J. 2015; 36: 1660-1668

View in Article

Scopus (179)

PubMed

Crossref

Google Scholar

Botto G.L.

Padeletti L.

Santini M.

et al.

Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events.

J Cardiovasc Electrophysiol. 2009; 20: 241-248

View in Article

Scopus (267)

PubMed

Crossref

Google Scholar

Van Gelder I.C.

Healey J.S.

Crijns H.J.G.M.

Wang J.

Hohnloser S.H.

Gold M.R.

Capucci A.

Lau C.P.

Morillo C.A.

Hobbelt A.H.

Rienstra M.

Connolly S.J.

Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT.

Eur Heart J. 2017; 38: 1339-1344

View in Article

Scopus (165)

PubMed

Crossref

Google Scholar

Lopes R.D.

Alings M.

Connolly S.J.

et al.

Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial.

Am Heart J. 2017; 189: 137-145

View in Article

Scopus (93)

PubMed

Abstract

Full Text

Full Text PDF

Google Scholar

Kirchhof P.

Blank B.F.

Calvert M.

Camm A.J.

Chlouverakis G.

Diener H.C.

Goette A.

Huening A.

Lip G.Y.H.

Simantirakis E.

Vardas P.

Probing oral anticoagulation in patients with atrial high rate episodes: rationale and design of the Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial.

Am Heart J. 2017; 190: 12-18

View in Article

Scopus (83)

PubMed

Abstract

Full Text

Full Text PDF

Google Scholar

Swiryn S.

Orlov M.V.

Benditt D.G.

DiMarco J.P.

Lloyd-Jones D.M.

Karst E.

Qu F.

Slawsky M.T.

Turkel M.

Waldo A.L.

RATE Registry Investigators

Clinical implications of brief device-detected atrial tachyarrhythmias in a cardiac rhythm management device population: results from the Registry of Atrial Tachycardia and Atrial Fibrillation Episodes.

Circulation. 2016; 134: 1130-1140

View in Article

Scopus (56)

PubMed

Crossref

Google Scholar

Article Info

Publication History

Published online: February 22, 2018

Footnotes

Data collection and analysis were performed in the framework of the Home Monitoring Expert Alliance (HMEA), an investigator-initiated nationwide repository of data. Technical and logistical support necessary for this research was provided by BIOTRONIK Italia, which is not the sponsor of the study and does not provide grants or fees per patient. Mr. Giacopelli and Mr. Gargaro are employees of BIOTRONIK Italia. All other authors have reported that they have no conflicts relevant to the contents of this paper to disclose.


Identification

DOI: https://doi.org/10.1016/j.hrthm.2018.02.023


Copyright

© 2018 Published by Elsevier Inc. on behalf of Heart Rhythm Society.

ScienceDirect

Access this article on ScienceDirect

Related Articles

European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population

Heart Rhythm

In BriefFull-TextPDF

Open Access

2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: Executive summary

Heart RhythmVol. 13Issue 4

In BriefFull-TextPDF

2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy

Heart RhythmVol. 16Issue 11

In BriefFull-TextPDF

2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay

Heart RhythmVol. 16Issue 9

In BriefFull-TextPDF

2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

Heart RhythmVol. 15Issue 10

In BriefFull-TextPDF

EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication

Heart RhythmVol. 14Issue 1

In BriefFull-TextPDF

2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia

Heart RhythmVol. 13Issue 4

In BriefFull-TextPDF

2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation

Heart RhythmVol. 16Issue 8

In BriefFull-TextPDF

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation

Heart RhythmVol. 14Issue 10

In BriefFull-TextPDF

Open Access

2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias

Heart RhythmVol. 17Issue 1

In BriefFull-TextPDF

Open Access


Comments

Popular posts from this blog

Coronavirus Australia: Everything you need to know about Melbourne’s stage four exit road map

Amber alert issued for two children taken from a Queensland home

In Australia, we’ve got our seasons all wrong